AI assistant
Minerva Neurosciences, Inc. — Director's Dealing 2019
Dec 17, 2019
35086_dirs_2019-12-17_ca12e8bc-40a8-4f94-889c-04a347d9a212.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2019-12-14
Reporting Person: Race Geoff (EVP, CFO & CBO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-14 | Common Stock | M | 12500 | — | Acquired | 210870 | Direct |
| 2019-12-17 | Common Stock | S | 5826 | $7.10 | Disposed | 205044 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-14 | Restricted Stock Unit | $ | M | 12500 | Disposed | Common Stock (12500) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2: Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock grants.
F3: Represents shares issuable upon the vesting of RSUs awarded to the Reporting Person on December 14, 2016. The RSUs vest in 4 equal annual installments beginning on December 14, 2017 and will be fully vested on December 14, 2020, in all cases so long as there has been no break in the Reporting Person's continuous service through such date.